Number of the records: 1  

Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease.

  1. 1.
    SYSNO ASEP0579872
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleAutoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease.
    Author(s) Gruper, Y. (IL)
    Wolff, A. S. B. (NO)
    Glanz, L. (IL)
    Špoutil, František (UMG-J)
    Marthinussen, M. C. (NO)
    Osičková, Adriana (MBU-M) RID, ORCID
    Herzig, Y. (IL)
    Goldfarb, Y. (IL)
    Aranaz-Novaliches, Gorreti (UMG-J)
    Dobeš, J. (CZ)
    Kadouri, N. (IL)
    Ben-Nun, O. (IL)
    Binyamin, A. (IL)
    Lavi, B. (IL)
    Givony, T. (IL)
    Khalaila, R. (IL)
    Gome, T. (IL)
    Wald, Tomáš (MBU-M) RID
    Mrázková, Blanka (UMG-J)
    Sochen, C. (IL)
    Besnard, M. (FR)
    Ben-Dor, S. (IL)
    Feldmesser, E. (IL)
    Orlova, E. M. (RU)
    Hegedus, C. (HU)
    Lampe, I. (HU)
    Papp, T. (HU)
    Felszeghy, S. (HU)
    Sedláček, Radislav (UMG-J) RID
    Davidovich, E. (IL)
    Tal, N. (IL)
    Shouval, D. S. (IL)
    Shamir, R. (IL)
    Guillonneau, C. (IL)
    Szondy, Z. (IL)
    Lundin, K. E. A. (NO)
    Osička, Radim (MBU-M) RID, ORCID
    Procházka, Jan (UMG-J) ORCID
    Husebye, E. S. (NO)
    Abramson, J. (IL)
    Number of authors40
    Source TitleNature. - : Palgrave Macmillan - ISSN 0028-0836
    Roč. 624, č. 7992 (2023), s. 653-662
    Number of pages39 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsantibody ; enamel ; immune response ; protein ; tolerance ; tooth
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsLM2023053 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LM2018126 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LM2023036 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF16_013/0001789 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF18_046/0015861 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    GJ19-19025Y GA ČR - Czech Science Foundation (CSF)
    LM2018129 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    EF18_046/0016045 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingLimited access
    Institutional supportUMG-J - RVO:68378050 ; MBU-M - RVO:61388971
    UT WOS001112504800001
    EID SCOPUS85177589789
    DOI10.1038/s41586-023-06776-0
    AnnotationAmeloblasts are specialized epithelial cells in the jaw that have an indispensable role in tooth enamel formation-amelogenesis1. Amelogenesis depends on multiple ameloblast-derived proteins that function as a scaffold for hydroxyapatite crystals. The loss of function of ameloblast-derived proteins results in a group of rare congenital disorders called amelogenesis imperfecta2. Defects in enamel formation are also found in patients with autoimmune polyglandular syndrome type-1 (APS-1), caused by AIRE deficiency3,4, and in patients diagnosed with coeliac disease5-7. However, the underlying mechanisms remain unclear. Here we show that the vast majority of patients with APS-1 and coeliac disease develop autoantibodies (mostly of the IgA isotype) against ameloblast-specific proteins, the expression of which is induced by AIRE in the thymus. This in turn results in a breakdown of central tolerance, and subsequent generation of corresponding autoantibodies that interfere with enamel formation. However, in coeliac disease, the generation of such autoantibodies seems to be driven by a breakdown of peripheral tolerance to intestinal antigens that are also expressed in enamel tissue. Both conditions are examples of a previously unidentified type of IgA-dependent autoimmune disorder that we collectively name autoimmune amelogenesis imperfecta.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2024
    Electronic addresshttps://www.nature.com/articles/s41586-023-06776-0
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.